Patients with acromegaly require fortnightly or monthly injections of somatostatin analogs during clinic visits. The introduction of lanreotide, in the form of Somatuline Autogel ® (SCRAS ...

The authors conclude that the time interval between injections of lanreotide can be prolonged to 6 weeks in patients whose acromegaly is well-controlled on 4-weekly injections, without loss of ...

However, the combination of lanreotide and everolimus has not previously been studied, ASCO expert Laura Vater, MD, MPH, with Indiana University Simon Cancer Center, Indianapolis, said in a statement.